Hickethier, Tilman ORCID: 0000-0001-9303-9470, Kroeger, Jan Robert, Von Spiczak, Jochen, Baessler, Bettina
ORCID: 0000-0002-3244-3864, Pfister, Roman, Maintz, David, Bunck, Alexander C. and Michels, Guido
(2016).
Non-invasive imaging of bioresorbable coronary scaffolds using CT and MRI: First in vitro experience.
Int. J. Cardiol., 206.
S. 101 - 107.
CLARE:
ELSEVIER IRELAND LTD.
ISSN 1874-1754
Abstract
Background: Accurate assessment of coronary stents after PCI using non-invasive imaging remains challenging despite technological improvements. New bioresorbable vascular scaffolds (BVS) have recently become available promising improved non-invasive imaging properties, which however have not be examined specifically yet. Therefore we investigated CT and MRI visualization properties of the only two CE-marked coronary BVSs. Methods: The Abbott Absorb and the Elixir DESolve BVS were placed in plastic tubes filled with contrast agent and scanned with a latest generation CT respectively MR system. For CT image quality was assessed by two blinded, independent readers and in-scaffold diameter difference as well as in-scaffold attenuation difference were measured. For MRI in-scaffold signal intensity, in-scaffold lumen visibility and in-scaffold signal homogeneity were measured. Results: In CTA both BVSs showed no significant difference to nominal tube diameter (DESolve 101%, Absorb 100%) and to nominal tube attenuation (DESolve 96%, Absorb 98%) and were both rated with the highest score for unrestricted lumen visualization. In MRA both BVSs showed unimpaired signal intensity (DESolve 103%, Absorb 100%), lumen visibility (DESolve 92%, Absorb 89%) and lumen homogeneity (DESolve SD 7.1%, Absorb SD 9.5%) when compared to the unstented tube. There was no significant difference between CTA and MRA results of both BVSs. Conclusions: Coronary BVSs show no relevant impairment for subjective and objective measures of in-stent lumen visualization by CT and MRI and will therefore allow reliable non-invasive assessment of coronary artery patency after PCI with deployment of a BVS, which is an (additional) advantage when compared to conventional stents. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
Item Type: | Journal Article | ||||||||||||||||||||||||||||||||||||
Creators: |
|
||||||||||||||||||||||||||||||||||||
URN: | urn:nbn:de:hbz:38-283757 | ||||||||||||||||||||||||||||||||||||
DOI: | 10.1016/j.ijcard.2016.01.028 | ||||||||||||||||||||||||||||||||||||
Journal or Publication Title: | Int. J. Cardiol. | ||||||||||||||||||||||||||||||||||||
Volume: | 206 | ||||||||||||||||||||||||||||||||||||
Page Range: | S. 101 - 107 | ||||||||||||||||||||||||||||||||||||
Date: | 2016 | ||||||||||||||||||||||||||||||||||||
Publisher: | ELSEVIER IRELAND LTD | ||||||||||||||||||||||||||||||||||||
Place of Publication: | CLARE | ||||||||||||||||||||||||||||||||||||
ISSN: | 1874-1754 | ||||||||||||||||||||||||||||||||||||
Language: | English | ||||||||||||||||||||||||||||||||||||
Faculty: | Unspecified | ||||||||||||||||||||||||||||||||||||
Divisions: | Unspecified | ||||||||||||||||||||||||||||||||||||
Subjects: | no entry | ||||||||||||||||||||||||||||||||||||
Uncontrolled Keywords: |
|
||||||||||||||||||||||||||||||||||||
Refereed: | Yes | ||||||||||||||||||||||||||||||||||||
URI: | http://kups.ub.uni-koeln.de/id/eprint/28375 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |